WilmerHale Represents General Catalyst in Connection with $18.5 Billion Deal

WilmerHale Represents General Catalyst in Connection with $18.5 Billion Deal

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
WilmerHale has advised General Catalyst, the largest shareholder of Livongo, in connection with the merger of Livongo and Teladoc Health. The merger, valued at $18.5 billion, brings together complementary leaders in virtual care and chronic condition management to create a global leader in consumer centered virtual care. The transaction is expected to close by the end of the fourth quarter of 2020, subject to customary closing conditions.

The WilmerHale team representing General Catalyst includes Jason Kropp, Hal Leibowitz, Andrew Bonnes and Molly Fox.

Read the full press release.
 

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel